Lianjing Green Technology Co., Ltd. in New Taipei City has self-reported that its manufactured 'Lianjing Bitter Tea Oil' contains benzopyrene, a Group 1 carcinogen. The contaminated product's raw material—tea seeds—was imported from China. Early this morning (23rd), the Food and Drug Administration (FDA) and the New Taipei City Health Bureau conducted an on-site inspection at the company, collecting five samples of bitter tea oil for testing, which the FDA will analyze. Subsequent actions by central and local authorities will be determined based on the test results.
The company reported late last night that benzopyrene levels in its bitter tea oil reached 2.9 ppb, exceeding the legal limit of 2.0 ppb. The FDA and New Taipei City Health Bureau visited the facility today to conduct audits. According to Liu Fang-Ming, Director of the FDA’s Northern Regional Office, the affected batch was produced by Lianjing and sold through retailers such as Cottonfield Organic Garden and Uni-President Organic Health Stores.
The New Taipei City Health Bureau has ordered the immediate suspension of all bitter tea oil sales. Lianjing stated that upon reporting to the city government, it proactively notified downstream distributors to fully remove and recall the related products from shelves.
Additional exclusive reports from Storm Media include: - Could the Zhonglian carcinogenic oil incident have been avoided? A critic reveals how eight years of legislative inaction under a single-party government led to disaster: 'The public consumed toxic oil for an extra 26 days.' - In the Zhonglian carcinogenic oil scandal, who is to blame—central or local government? A writer highlights a statement from the Ministry of Health and Welfare that 'exposes' the truth: 'Lu Hsiu-yen laughed.' - Has the culprit behind the carcinogenic oil been identified? Zhonglian relaxed soybean standards 'tenfold,' and Shih Chong-liang stated: 'Oil production processes were not properly controlled.'
FACT BOX
- Source: PR Times
- Category: News